Found 4 matching trials
The Dosing Regimen of Pyrotinib in HER2-positive Advanced First-line Breast Cancer: a Phase II Clinical Study PHASE2 Evaluate the safety and efficacy of Pyrotinib in the transition from low-do...
Show More Location
Jiangsu Provincial People's Hospital
Learn More & Join Trial
Pyrotinib Combined With Trastuzumab, Dalpiciclib, Letrozole Versus TCbHP (Trastuzumab Plus Pertuzumab With Docetaxel and Carboplatin) as Neoadjuvant Treatment in HR +/HER2 + Breast Cancer PHASE2 This is an investigator-initiated randomized controlled, open-label, multic...
Show More Location
Shengjing Hospital of China Medical University
Learn More & Join Trial
The Dosing Regimen of Pyrotinib in HER2-positive Advanced First-line Breast Cancer: a Phase I Clinical Study PHASE1 Evaluate the safety and efficacy of Pyrotinib at different doses in combina...
Show More Location
Jiangsu Provincial People's Hospital
Learn More & Join Trial
Exploratory Study of Molecular Profile-Associated Evidence Guided Precision Therapy for Salivary Gland Cancer(MAPS) N/A To explore the feasibility, efficacy and safety of determining the treatmen...
Show More Location
Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University
Learn More & Join Trial